113 related articles for article (PubMed ID: 342393)
61. Peritoneal macrophage response to leukemia L1210 in syngeneic mice.
Berd D; Prehn RT
J Natl Cancer Inst; 1977 Jun; 58(6):1729-34. PubMed ID: 864751
[No Abstract] [Full Text] [Related]
62. Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/C mice.
Law LW
Int J Cancer; 1980 Feb; 25(2):251-9. PubMed ID: 6156130
[TBL] [Abstract][Full Text] [Related]
63. Specificity of cell-mediated transplantation reactions. II. Studies with a sensitive assay of cell-mediated cytotoxicity.
Lake P; Sabbadini E; Sehon AH
Immunology; 1974 Sep; 27(3):441-55. PubMed ID: 4137937
[TBL] [Abstract][Full Text] [Related]
64. Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice.
Morton JI; Siegel BV
Proc Natl Acad Sci U S A; 1974 Jun; 71(6):2162-5. PubMed ID: 4601580
[TBL] [Abstract][Full Text] [Related]
65. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response.
Stackpole CW; Demsey A
Invasion Metastasis; 1984; 4(1):28-46. PubMed ID: 6329988
[TBL] [Abstract][Full Text] [Related]
66. [Sensitization of murine splenocytes to normal tissue antigens and natural killer activity. II. The effect of immunization with allogeneic and xenogeneic tissues].
Pogodina ON; Malygin AM; Pleskach VA; Fel' VIa
Tsitologiia; 1985 Dec; 27(12):1419-22. PubMed ID: 3911518
[TBL] [Abstract][Full Text] [Related]
67. Uptake of 5-iododeoxyuridine as a measure of tumor growth and tumor inhibition.
Bonmassar E; Houchens DP; Fioretti MC; Goldin A
Chemotherapy; 1975; 21(6):321-9. PubMed ID: 1183242
[TBL] [Abstract][Full Text] [Related]
68. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
69. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
70. Allosensitization protects against lethal challenge with a syngeneic mouse lymphoma.
Bear RH; Roholt OA; Pressman D
Transplant Proc; 1980 Mar; 12(1):150-1. PubMed ID: 7368286
[No Abstract] [Full Text] [Related]
71. Correlations of in vivo growth of CTL-susceptible and -resistant variant tumor cell lines in CTL-responder AKR.H-2b:Fv-1b and -nonresponder AKR.H-2b mice.
Azuma H; Wegmann KW; Green WR
Cell Immunol; 1988 Oct; 116(1):123-34. PubMed ID: 3262427
[TBL] [Abstract][Full Text] [Related]
72. Adoptive immunochemotherapy of a transplantable AKR leukemia (K36).
Putman DL; Kind PD; Goldin A; Kende M
Int J Cancer; 1978 Feb; 21(2):230-3. PubMed ID: 24004
[TBL] [Abstract][Full Text] [Related]
73. Are tumor-associated transplantation antigens of chemically induced sarcomas related to alien histocompatibility antigens?
Pliskin ME; Prehn RT
Transplantation; 1978 Jul; 26(1):19-24. PubMed ID: 354118
[TBL] [Abstract][Full Text] [Related]
74. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
Bosslet K; Schirrmacher V; Shantz G
Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
[No Abstract] [Full Text] [Related]
75. Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.
Testorelli C; Archetti YL; Aresca P; Del Vecchio L
Cancer Res; 1985 Nov; 45(11 Pt 1):5299-303. PubMed ID: 4053006
[TBL] [Abstract][Full Text] [Related]
76. Mutant lines of guinea pig L2C leukemia. I. Deletion of Ia alloantigens is associated with a loss in immunogenicity of tumor-associated transplantation antigens.
Forni G; Shevach EM; Green I
J Exp Med; 1976 May; 143(5):1067-81. PubMed ID: 1262783
[TBL] [Abstract][Full Text] [Related]
77. Development of tumors as a result of graft-versus-host reaction.
Cornelius EA
Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
[No Abstract] [Full Text] [Related]
78. Protection against transplanted and spontaneous lymphoma by inoculation of heat-altered syngeneic tumor cells in splenectomized mice.
Check JH; Brady LW; Leipold PL; O'Neill EA
Cancer; 1974 Jul; 34(1):197-203. PubMed ID: 4834179
[No Abstract] [Full Text] [Related]
79. [Effect of interferon on the immune response of mice to immunization with the cells of transplantable leukemias and sarkomas].
Skurkovich SV; Ol'shanskaia NV; Kalinina IA; Klinova EG; Eremkina EI
Vopr Onkol; 1977; 23(9):44-50. PubMed ID: 910422
[TBL] [Abstract][Full Text] [Related]
80. Resistance to syngeneic lymphoma cells as a result of immunization with chemically modified allogeneic lymphoma cells in mice.
Gillette RW; Berringer DC; Wunderlich DA
J Natl Cancer Inst; 1978 Jun; 60(6):1427-32. PubMed ID: 650705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
